Article Versions Notes

Elshazly AM, Xu J, Melhem N, Abdulnaby A, Elzahed AA, Saleh T, Gewirtz DA. Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers. 2024; 16(17):2989. https://doi.org/10.3390/cancers16172989

Elshazly, Ahmed M., Jingwen Xu, Nebras Melhem, Alsayed Abdulnaby, Aya A. Elzahed, Tareq Saleh, and David A. Gewirtz. 2024. "Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors?" Cancers 16, no. 17: 2989. https://doi.org/10.3390/cancers16172989

Elshazly, A. M., Xu, J., Melhem, N., Abdulnaby, A., Elzahed, A. A., Saleh, T., & Gewirtz, D. A. (2024). Is Autophagy Targeting a Valid Adjuvant Strategy in Conjunction with Tyrosine Kinase Inhibitors? Cancers, 16(17), 2989. https://doi.org/10.3390/cancers16172989